Nu Skin Enterprises (NYSE:NUS)‘s stock had its “buy” rating reaffirmed by equities research analysts at Tigress Financial in a report issued on Wednesday.
A number of other research analysts have also issued reports on the company. Citigroup set a $88.00 target price on Nu Skin Enterprises and gave the company a “buy” rating in a report on Thursday, November 8th. Jefferies Financial Group reissued a “buy” rating and issued a $92.00 target price on shares of Nu Skin Enterprises in a report on Thursday, November 8th. Zacks Investment Research lowered Nu Skin Enterprises from a “hold” rating to a “sell” rating in a report on Tuesday, October 23rd. DA Davidson assumed coverage on Nu Skin Enterprises in a report on Tuesday, October 9th. They issued a “buy” rating and a $92.00 target price on the stock. Finally, Stifel Nicolaus raised Nu Skin Enterprises from a “sell” rating to a “hold” rating and boosted their target price for the company from $57.00 to $70.00 in a report on Thursday, August 2nd. They noted that the move was a valuation call. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and six have assigned a buy rating to the company’s stock. Nu Skin Enterprises currently has an average rating of “Buy” and an average price target of $86.29.
NYSE:NUS opened at $66.12 on Wednesday. The company has a market capitalization of $3.67 billion, a PE ratio of 20.47, a P/E/G ratio of 1.68 and a beta of 1.04. The company has a current ratio of 1.93, a quick ratio of 1.25 and a debt-to-equity ratio of 0.44. Nu Skin Enterprises has a 12-month low of $60.60 and a 12-month high of $88.68.
In related news, General Counsel D Matthew Dorny sold 2,500 shares of the company’s stock in a transaction on Monday, October 1st. The stock was sold at an average price of $82.18, for a total transaction of $205,450.00. Following the transaction, the general counsel now owns 33,871 shares of the company’s stock, valued at $2,783,518.78. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders have sold 7,500 shares of company stock worth $568,550 in the last ninety days. 5.20% of the stock is currently owned by corporate insiders.
Hedge funds have recently made changes to their positions in the stock. BlackRock Inc. grew its holdings in Nu Skin Enterprises by 11.5% in the second quarter. BlackRock Inc. now owns 6,143,407 shares of the company’s stock valued at $480,352,000 after purchasing an additional 635,246 shares during the last quarter. William Blair Investment Management LLC grew its holdings in Nu Skin Enterprises by 6.8% in the third quarter. William Blair Investment Management LLC now owns 1,263,139 shares of the company’s stock valued at $104,108,000 after purchasing an additional 80,117 shares during the last quarter. Bank of New York Mellon Corp grew its holdings in Nu Skin Enterprises by 0.4% in the third quarter. Bank of New York Mellon Corp now owns 820,216 shares of the company’s stock valued at $67,601,000 after purchasing an additional 3,213 shares during the last quarter. Renaissance Technologies LLC grew its holdings in Nu Skin Enterprises by 51.1% in the second quarter. Renaissance Technologies LLC now owns 814,000 shares of the company’s stock valued at $63,647,000 after purchasing an additional 275,200 shares during the last quarter. Finally, MERIAN GLOBAL INVESTORS UK Ltd grew its holdings in Nu Skin Enterprises by 4.2% in the third quarter. MERIAN GLOBAL INVESTORS UK Ltd now owns 746,830 shares of the company’s stock valued at $61,553,000 after purchasing an additional 29,880 shares during the last quarter. 76.52% of the stock is currently owned by hedge funds and other institutional investors.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.
Recommended Story: Technical Analysis
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.